TELA Bio to Announce Second Quarter 2025 Financial Results
TELA Bio (NASDAQ: TELA), a medical technology company specializing in soft-tissue reconstruction solutions, has scheduled its second quarter 2025 financial results announcement for Monday, August 11, 2025.
The company will host a conference call and webcast at 4:30 p.m. ET on the same day, featuring management's discussion of financial results and a corporate update. Interested investors must register in advance or at least 15 minutes before the call. The webcast and replay will be accessible through the Events & Presentations section of TELA's investor website.
TELA Bio (NASDAQ: TELA), azienda tecnologica nel settore medico specializzata in soluzioni per la ricostruzione dei tessuti molli, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per lunedì 11 agosto 2025.
La società terrà una conference call e webcast alle 16:30 ET lo stesso giorno, durante la quale la direzione discuterà i risultati finanziari e fornirà un aggiornamento aziendale. Gli investitori interessati devono registrarsi in anticipo o almeno 15 minuti prima della chiamata. Il webcast e la registrazione saranno disponibili nella sezione Eventi e Presentazioni del sito web per gli investitori di TELA.
TELA Bio (NASDAQ: TELA), una empresa de tecnología médica especializada en soluciones para la reconstrucción de tejidos blandos, ha programado el anuncio de resultados financieros del segundo trimestre de 2025 para el lunes 11 de agosto de 2025.
La compañía realizará una llamada en conferencia y webcast a las 4:30 p.m. ET ese mismo día, donde la dirección discutirá los resultados financieros y ofrecerá una actualización corporativa. Los inversores interesados deben registrarse con anticipación o al menos 15 minutos antes de la llamada. El webcast y la repetición estarán disponibles en la sección de Eventos y Presentaciones del sitio web para inversores de TELA.
TELA Bio (나스닥: TELA)는 연조직 재건 솔루션을 전문으로 하는 의료기술 회사로, 2025년 8월 11일 월요일에 2025년 2분기 재무실적 발표를 예정하고 있습니다.
회사는 같은 날 동부 표준시 기준 오후 4시 30분에 컨퍼런스 콜 및 웹캐스트를 진행하며, 경영진이 재무 결과와 기업 현황에 대해 논의할 예정입니다. 관심 있는 투자자는 사전에 또는 콜 시작 최소 15분 전에 등록해야 합니다. 웹캐스트와 다시보기는 TELA 투자자 웹사이트의 이벤트 및 프레젠테이션 섹션에서 확인할 수 있습니다.
TELA Bio (NASDAQ : TELA), une entreprise de technologie médicale spécialisée dans les solutions de reconstruction des tissus mous, a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le lundi 11 août 2025.
La société organisera le même jour une conférence téléphonique et une diffusion en direct à 16h30 ET, au cours desquelles la direction présentera les résultats financiers et une mise à jour de l'entreprise. Les investisseurs intéressés doivent s'inscrire à l'avance ou au moins 15 minutes avant l'appel. La diffusion en direct et le replay seront accessibles via la section Événements et Présentations du site web des investisseurs de TELA.
TELA Bio (NASDAQ: TELA), ein Medizintechnikunternehmen, das sich auf Lösungen zur Rekonstruktion von Weichgewebe spezialisiert hat, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für Montag, den 11. August 2025 angekündigt.
Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz und ein Webcast veranstalten, bei der das Management die Finanzergebnisse besprechen und ein Unternehmensupdate geben wird. Interessierte Investoren müssen sich im Voraus oder mindestens 15 Minuten vor Beginn der Konferenz anmelden. Der Webcast und die Aufzeichnung sind über den Bereich „Events & Presentations“ auf der Investorenseite von TELA zugänglich.
- None.
- None.
MALVERN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report second quarter 2025 financial results on Monday, August 11, 2025. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Second Quarter Earnings Conference Call and Webcast Details
Investors interested in listening to the conference call should register online. Participants are required to register a day in advance or at minimum 15 minutes before the start of the call. A live webcast and replay can be accessed via the Events & Presentations page of the investor section of TELA's website.
About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Caution Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations are forward-looking statements and reflect the current beliefs of TELA Bio's management. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors that could cause actual results and events to differ materially and adversely from those indicated by such forward-looking statements. These risks and uncertainties are described more fully in the "Risk Factors" section and elsewhere in our filings with the Securities and Exchange Commission and available at www.sec.gov, including in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements that we make in this announcement speak only as of the date of this press release, and TELA Bio assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise after the date of this press release, except as required under applicable law.
Investor Contact
Louisa Smith
ir@telabio.com
FAQ
When will TELA Bio (NASDAQ: TELA) release Q2 2025 earnings?
What time is TELA Bio's Q2 2025 earnings call?
How can investors access TELA Bio's Q2 2025 earnings call?
What does TELA Bio (NASDAQ: TELA) specialize in?
